BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 11684630)

  • 1. Nonselective versus selective beta-adrenergic receptor blockade in congestive heart failure: differential effects on sympathetic activity.
    Azevedo ER; Kubo T; Mak S; Al-Hesayen A; Schofield A; Allan R; Kelly S; Newton GE; Floras JS; Parker JD
    Circulation; 2001 Oct; 104(18):2194-9. PubMed ID: 11684630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization.
    Al-Hesayen A; Azevedo ER; Floras JS; Hollingshead S; Lopaschuk GD; Parker JD
    Eur J Heart Fail; 2005 Jun; 7(4):618-23. PubMed ID: 15921803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of beta 1-selective and nonselective beta-adrenergic receptor blockade on cardiac sympathetic activity in congestive heart failure.
    Newton GE; Parker JD
    Circulation; 1996 Aug; 94(3):353-8. PubMed ID: 8759076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differing beta-blocking effects of carvedilol and metoprolol.
    Stoschitzky K; Koshucharova G; Zweiker R; Maier R; Watzinger N; Fruhwald FM; Klein W
    Eur J Heart Fail; 2001 Jun; 3(3):343-9. PubMed ID: 11378006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of nonselective versus selective β-blockers on cardiac sympathetic activity and hemostasis in patients with heart failure.
    de Peuter OR; Verberne HJ; Kok WE; van den Bogaard B; Schaap MC; Nieuwland R; Meijers JC; Somsen GA; Bakx A; Kamphuisen PW
    J Nucl Med; 2013 Oct; 54(10):1733-9. PubMed ID: 23970363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of carvedilol and metoprolol succinate on plasma norepinephrine release and peak exercise heart rate in subjects with chronic heart failure.
    Vittorio TJ; Zolty R; Kasper ME; Khandwalla RM; Hirsh DS; Tseng CH; Jorde UP; Ahuja K
    J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):51-7. PubMed ID: 18287590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of combined versus selective adrenergic blockade on left ventricular and systemic hemodynamics, myocardial substrate preference, and regional perfusion in conscious dogs with dilated cardiomyopathy.
    Nikolaidis LA; Poornima I; Parikh P; Magovern M; Shen YT; Shannon RP
    J Am Coll Cardiol; 2006 May; 47(9):1871-81. PubMed ID: 16682315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-blockade restores muscle sympathetic rhythmicity in human heart failure.
    Kubo T; Azevedo ER; Newton GE; Picton P; Parker JD; Floras JS
    Circ J; 2011; 75(6):1400-8. PubMed ID: 21519151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of carvedilol and metoprolol on regional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure.
    Hryniewicz K; Androne AS; Hudaihed A; Katz SD
    Circulation; 2003 Aug; 108(8):971-6. PubMed ID: 12912816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
    Zebrack JS; Munger M; Macgregor J; Lombardi WL; Stoddard GP; Gilbert EM
    Pharmacotherapy; 2009 Aug; 29(8):883-90. PubMed ID: 19637941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart.
    Gilbert EM; Abraham WT; Olsen S; Hattler B; White M; Mealy P; Larrabee P; Bristow MR
    Circulation; 1996 Dec; 94(11):2817-25. PubMed ID: 8941107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial.
    Metra M; Torp-Pedersen C; Swedberg K; Cleland JG; Di Lenarda A; Komajda M; Remme WJ; Lutiger B; Scherhag A; Lukas MA; Charlesworth A; Poole-Wilson PA
    Eur Heart J; 2005 Nov; 26(21):2259-68. PubMed ID: 16040619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effects of intravenous carvedilol versus metoprolol on baroreflex-mediated sympathetic circulatory regulation in rats.
    Yamamoto H; Kawada T; Shimizu S; Hayama Y; Shishido T; Iwanaga Y; Fukuda K; Miyazaki S; Sugimachi M
    Int J Cardiol; 2019 Jun; 285():65-71. PubMed ID: 30876665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blockade in heart failure: a comparison of carvedilol with metoprolol.
    Sanderson JE; Chan SK; Yip G; Yeung LY; Chan KW; Raymond K; Woo KS
    J Am Coll Cardiol; 1999 Nov; 34(5):1522-8. PubMed ID: 10551702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of evidence for peripheral alpha(1)- adrenoceptor blockade during long-term treatment of heart failure with carvedilol.
    Kubo T; Azevedo ER; Newton GE; Parker JD; Floras JS
    J Am Coll Cardiol; 2001 Nov; 38(5):1463-9. PubMed ID: 11691524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective versus nonselective beta-blockade for heart failure therapy: are there lessons to be learned from the COMET trial?
    Bristow MR; Feldman AM; Adams KF; Goldstein S
    J Card Fail; 2003 Dec; 9(6):444-53. PubMed ID: 14966783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective or nonselective beta-adrenergic blockade in patients with congestive heart failure.
    Metra M; Nodari S; Boldi E; Dei Cas L
    Curr Cardiol Rep; 2000 May; 2(3):252-7. PubMed ID: 10980900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial reversal of cachexia by beta-adrenergic receptor blocker therapy in patients with chronic heart failure.
    Hryniewicz K; Androne AS; Hudaihed A; Katz SD
    J Card Fail; 2003 Dec; 9(6):464-8. PubMed ID: 14966787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
    Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA;
    Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.